ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $676,368 | +98066.6% | 10,071 | -1.0% | 0.27% | +3.5% |
| Q2 2023 | $689 | +23.9% | 10,170 | -1.0% | 0.26% | +19.4% |
| Q1 2023 | $556 | -11.5% | 10,277 | -2.1% | 0.22% | -14.6% |
| Q4 2022 | $628 | -99.9% | 10,500 | -0.8% | 0.25% | +11.9% |
| Q3 2022 | $479,000 | -10.5% | 10,587 | +10.9% | 0.23% | -9.2% |
| Q2 2022 | $535,000 | +13.8% | 9,547 | +44.6% | 0.25% | +30.9% |
| Q1 2022 | $470,000 | +6.8% | 6,603 | -2.0% | 0.19% | +14.4% |
| Q4 2021 | $440,000 | -26.2% | 6,739 | -15.1% | 0.17% | -25.8% |
| Q3 2021 | $596,000 | -3.7% | 7,936 | +0.0% | 0.22% | -5.9% |
| Q2 2021 | $619,000 | -3.3% | 7,933 | +1.5% | 0.24% | -11.2% |
| Q1 2021 | $640,000 | +3.1% | 7,813 | +4.1% | 0.27% | +3.5% |
| Q4 2020 | $621,000 | +24.9% | 7,507 | -1.8% | 0.26% | -1.5% |
| Q3 2020 | $497,000 | +5.5% | 7,646 | +0.4% | 0.26% | -36.8% |
| Q2 2020 | $471,000 | – | 7,613 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |